GlassScriptPhysician profile
Seth Swinney
NPI 1750025631
$1,559.85
in general payments reported to CMS, 2019-2025
17 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $349 · 2024: $798 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $694.20 | 2023-2025 | Lithovue, Accolade Sr, Ams 700 |
| Endo Pharmaceuticals INC. | $133.10 | 2022-2023 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $126.80 | 2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $118.83 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $107.71 | 2024 | Bard Urinary Drainage Bag |
| Emd Serono, INC. | $99.95 | 2022 | |
| Axogen | $42.67 | 2025 | |
| Sumitomo Pharma America, INC. | $33.66 | 2023 | Gemtesa |
| Innovation Technologies INC | $29.37 | 2023 | Irrisept |
| Janssen Biotech, INC. | $26.66 | 2025 | Erleada |
| Endo USA, INC. | $26.25 | 2025 | Xiaflex |
| Photocure INC | $22.67 | 2025 | Cysview |
| Axonics, INC. | $22.40 | 2023 | Bulkamid |
| Astrazeneca Pharmaceuticals LP | $19.60 | 2024 | Lynparza |
| Astellas Pharma US INC | $18.85 | 2025 | Xtandi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.60 | 2024 | |
| Ferring Pharmaceuticals INC. | $18.53 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Swinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.